In Liverpool, England, 18 regular citizens spent 6 days learning about and discussing antimicrobial resistance (AMR) - when germs stop responding to medicines like antibiotics. The World Health Organization calls AMR one of the top 10 global health threats. These citizen jurors looked at different patient scenarios and made recommendations about how hospitals, companies, and government should work together to track and fight these drug-resistant germs.
They discussed how to share information between public and private organizations, guide individual treatments, identify trends in resistance, find areas needing new medicines, and shape public policy. The project was a partnership between the University of Liverpool, Pfizer pharmaceutical company, and the Center for New Democratic Processes. The citizens were chosen to represent different ages, backgrounds, and areas of Liverpool.
Their recommendations will help guide future research and policy decisions about fighting antimicrobial resistance. This innovative approach shows how everyday people can help solve complex health challenges by bringing their perspectives to scientific and policy discussions.